首页 | 本学科首页   官方微博 | 高级检索  
检索        

熊去氧胆酸联合中药治疗原发性胆汁性肝硬化临床疗效和安全性的Meta分析
引用本文:杨秀珍,韩立彬,沈美龙,咸建春.熊去氧胆酸联合中药治疗原发性胆汁性肝硬化临床疗效和安全性的Meta分析[J].光明中医,2013(12):2528-2530.
作者姓名:杨秀珍  韩立彬  沈美龙  咸建春
作者单位:江苏省泰州市人民医院肝病科,泰州225300
摘    要:目的 评价近5年来国内原发性胆汁性肝硬化熊去氧胆酸联合中药治疗的临床疗效与安全性.方法 选用中国知识资源总库(CNKI)、维普中文期刊数据库(VIP)、万方学术期刊全文数据库、中国生物医学文献服务系统(CBM)等作为资料源,对其2008年3月-2013年3月正式刊载的且Jadad量表评分2分以上的8篇熊去氧胆酸联合中药治疗疗效的随机对照试验(RCT)文献进行Meta分析,Jadad量表评分2分以上的8篇进行ALP的Meta分析,7篇进行GGT的Meta分析、6篇进行TBIL的Meta分析.结果 熊去氧胆酸联合中药治疗原发性胆汁性肝硬化疗明显高于对照组,且生化指标较对照组明显的下降.结论 熊去氧胆酸联合中药治疗原发性胆汁性肝硬化具有潜在的优势.

关 键 词:原发性胆汁性肝硬化  熊去氧胆酸  中西医结合疗法  Meta分析

Efficacy and Safety of UDTA and Integrated Traditional Chinese Medicine for Primary Biliiary Cirrhosis With Meta-analysis
Yang Xiuzhen,Han Libin,Shen Meilong,Xian Jianchun.Efficacy and Safety of UDTA and Integrated Traditional Chinese Medicine for Primary Biliiary Cirrhosis With Meta-analysis[J].Journal of Traditional Chinese Medicine,2013(12):2528-2530.
Authors:Yang Xiuzhen  Han Libin  Shen Meilong  Xian Jianchun
Institution:(Jiansu Taizhou People's Hospotal, Taizhou 225300)
Abstract:Objective To evaluate clinical effects and safety of integrated UDTA and traditional Chinese of primary biliiary cirrhosis in 5 years in domestic. Methods Literatures in periodical of CNK, VIP, Wan Fang, CBM, etc, were chosen from 2008 - 2013, which got 2 or more points after Jadad scale score of randomized controlled trials of primary biliiary cirrhosis and then to Meta-analysis. Results The clinical effects in UDTA and integrated traditional Chinese medicine of primary biliiary cirrhosis were higher than control group and biochemical indicator were lower than control group. Conclusion Using UDTA and traditional Chinese of primary biliiary cirrhosis were proved the clinical effects and safety.
Keywords:primary biliiary cirrhosis  UDTA  traditional Chinese medicine  TCWM  Meta-analysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号